Welcome to Sott.net
Fri, 21 Jan 2022
The World for People who Think

Health & Wellness


Deaths up 40% among those aged 18-64 based on life insurance claims for 2021 after COVID-19 vaccine roll outs

oneamerica life insurance building
Finally, the "elephant in the room" that nobody wanted to discuss in 2021 regarding labor shortages and supply chain bottlenecks, which is that record number of younger people in the workforce were dying after the roll-out of the COVID-19 "vaccines," can no longer be swept under the rug as statistics are being published that reveal a huge crisis developing in the United States.

Scott Davison, the CEO of OneAmerica, a $100 billion insurance company based out of Indiana, has come out publicly and stated that based on life insurance claims, the death rate has skyrocketed an unprecedented 40% among those between the ages of 18 and 64, based on the 3rd quarter and into the 4th quarter of 2021.

Comment: See also:


New research suggests COVID was less deadly than thought in first year of pandemic

COVID-19 was less lethal across nearly every age group in its first full year than previously thought, according to an updated review of global research from Stanford University's Meta-Research Innovation Center (METRIC).

Between summer and Christmas 2021, METRIC's estimates of deaths from infection fell by half in multiple age groups, including young people, and less sharply in others.

The international estimates, which have not been peer-reviewed, are not substantially different from the CDC's own "best estimate" of COVID mortality in the U.S., last updated in March. They use different age ranges, making exact comparisons difficult.

The findings raise questions about ongoing COVID restrictions and mandates, particularly for schoolchildren and college students, who remain at the lowest overall risk from infection.

The risk-benefit ratio of vaccine boosters is also under scrutiny, with international authorities souring on their wide deployment and a new Israeli study finding that a fourth dose of the Pfizer or Moderna vaccines doesn't stop the Omicron variant.

Chart Bar

Triple-jabbed over-30s have higher infection rates than the unvaccinated, UKHSA data show

Vaccinated infections 1
This week's UKHSA vaccine surveillance report has landed - and this week a change. In the (in)famous Table 12, which shows rates of infections, deaths and hospitalisations per 100,000 by vaccination status, the data have suddenly switched to giving rates for triple-jabbed rather than two-or-more doses, meaning we no longer have continuity with our previous data. So sudden was the change in fact, that the report itself has not kept up with it, and the notes under the table still say the rates are for "people who have received either two doses of a COVID-19 vaccine or in people who have not received a COVID-19 vaccine".

The change means we have to start over in our week-by-week comparisons, so the infection rates by age for this period are depicted above and the unadjusted vaccine effectiveness figures are depicted below.

Vaccinated infections 2
Below is how the total reported infections for the period break down by vaccination status (in this chart vaccinated means one or more doses). While the chart doesn't take into account the different numbers of people vaccinated and unvaccinated, with over 70% of infections in the vaccinated it does show that the outbreak is predominantly in vaccinated people.

Comment: See also:

Apple Green

The right to healthy food: Comorbidities & COVID-19

food additives
In early 2020, we saw the beginning of the COVID-19 'pandemic'. The world went into lockdown and even after lockdowns in various countries had been lifted, restrictions continued.

Data now shows that lockdowns seemingly had limited if any positive impacts on the trajectory of COVID-19 and in 2022 the world - especially the poor - is paying an immense price not least in terms of loss of income, loss of livelihoods, the deterioration of mental and physical health, the eradication of civil liberties, disrupted supply chains and shortages.

Before proceeding, the distinction should be made between dying from COVID and dying with COVID.

Those classified as dying with COVID include people entering hospital and testing positive while there, but they died due to other reasons, or they had chronic underlying conditions which possibly caused their death and COVID may or may not have been a complicating factor.

In the US, the Center for Disease Control provides a list of comorbid conditions in COVID-19 patients, which includes cancer, chronic kidney disease, heart disease, Down syndrome, obesity and type 2 diabetes mellitus.

Alarm Clock

CDC study finds natural immunity is superior to vaccine immunity: long-lasting and broad spectrum

covid virus
This undated transmission electron microscope image shows SARS-CoV-2, also known as novel coronavirus, the virus that causes COVID-19, isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab.

Comment: So the CDC has finally acknowledged the intuitive wisdom of centuries, not to mention a pile of previous studies. Huzzah?

A study by the U.S. CDC (a Federal Government health agency) has found that natural immunity is superior to vaccine immunity alone, and that being vaccinated on top makes little difference, confirming the findings of several studies in other countries.

The study looked at Covid infection and hospitalisation rates in California and New York during the Delta period, June to November 2021. The chart below shows the hazard rates over time for the four cohorts (no vaccine and no prior infection; no vaccine and prior infection; vaccine and no prior infection; vaccine and prior infection) for hospital admissions, adjusted for age - focus especially on the relative heights of the three dashed lines near the bottom.

The authors write: "These results demonstrate that vaccination protects against COVID-19 and related hospitalisation, and that surviving a previous infection protects against a reinfection and related hospitalisation." Note that the unvaccinated group here is split between those who are and are not previously infected, so is not directly comparable to the UKHSA data which does not make this distinction.



Why are pandemic babies developmentally stunted?

baby infant pacifier
© Getty Images / katleho Seisa
Babies born during the first year of the pandemic are developmentally and cognitively behind where they should be... and it isn't because of the virus itself. That is the shocking finding from a major new study in the journal JAMA Pediatrics on 255 babies born at a New York hospital between March and December of 2020.

In screening tests of gross motor, fine motor, and social skills done at the age of six months, pandemic babies scored lower than pre-pandemic babies. Whether the mother had Covid during the pregnancy, however, made no difference to the babies' development - regardless of how severe the infection was. So, if the damage wasn't down to the virus, what did cause it?

I spoke to Dr. Dani Dumitriu, co-author of the study and paediatrician at Columbia University, to find out more. She points out that although pandemic babies' scores were only slightly lower, these average differences could have profound long-term effects on an entire generation.

Comment: The extreme overreaction to a respiratory virus not much worse than a bad cold has cost our society dearly, but the effect on children is unforgivable. If there is any such thing as universal justice, the controllers behind the 'pandemic' will burn for this.

See also:


WHO says there's no evidence healthy children and adolescents need Covid boosters

Soumya Swaminathan who
© Fabrice Coffrini | Reuters
World Health Organization (WHO) Chief Scientist Soumya Swaminathan attends a press conference organised by the Geneva Association of United Nations Correspondents (ACANU) amid the COVID-19 outbreak, caused by the novel coronavirus, at the WHO headquarters in Geneva Switzerland July 3, 2020.
There's "no evidence right now" that suggests healthy children and adolescents need booster shots to supplement their Covid-19 vaccinations, World Health Organization Chief Scientist Dr. Soumya Swaminathan said Tuesday.

Swaminathan said the agency's advisory group, called Sage, or the Strategic Advisory Group of Experts on Immunization, will meet later this week to consider how countries should think about giving booster shots.

"The aim is to protect the most vulnerable, to protect those at highest risk of severe disease and dying, those are our elderly population, immunocompromised with underlying conditions and also health care workers," Swaminathan said WHO media briefing.

Dr. Michael Ryan, executive direction of the WHO's health emergencies program, said the agency still hasn't figured out how often or how many doses people will ultimately need.

Comment: See also:


Study finds that even mild cases of Covid-19 affect memory & attention

working memory
Moderate symptoms still cause long-term cognitive consequences, Oxford University researchers reveal

Scientists from Britain's Oxford University have revealed that people who have had mild Covid-19 and didn't suffer from other widespread 'long Covid' symptoms in daily life still show degraded attention and memory for six to nine months after infection.

Participants of the latest study had tested positive for Covid-19 previously, but didn't report any 'long Covid' symptoms often present after acute infection, nor other health concerns after recovery. They were not much different from an uninfected control group at the time of testing on factors such as fatigue, forgetfulness, sleep patterns or anxiety.

Comment: There are several factors not mentioned, such as the vaccination status of the 'mild' covid cases. The nature of the spike proteins of the SARs family are conducive to formation of microclots which can manifest many different symptoms of organ damage depending on where they form. The cognitive impairments reported sound suspiciously like micro-strokes.


Crumbling narrative: Study casts doubt on effectiveness of Covid testing at schools

covid test swab child children
© AP Photo/Elaine Thompson
A one year-old is held by his mother,while being tested for COVID-1
Low performance of antigen tests makes it difficult to evaluate the real scale of Omicron spread in schools

Rapid Covid-19 tests have demonstrated low effectiveness in detecting the virus in children, a team of British and German researchers has said, casting doubt on school testing programs.

Scientists from the University of Manchester and Germany's Institute for Quality and Efficiency in Health Care analyzed 17 studies published between January 2020 and May 2021, involving 6,355 children who used eight antigen tests from six different brands.

Comment: Took them long enough.


Large British study finds risk of myocarditis doubles after each mRNA jab

A study coming out of Britain showed an alarming increase in the risk for myocarditis, which is inflammation in the heart, after every mRNA jab, particularly in males under 40.

The study was published last month, and it analyzed data from over 42 million people 13 and older who have taken a COVID-19 shot. It was conducted by various researchers from institutions at the University of Oxford, University of Leicester, University of Edinburgh, King's College London and University of Nottingham.

The findings showed that myocarditis risk doubled after one jab, doubled again after a second jab and doubled yet again after a third booster jab.

"An association between COVID-19 infection and myocarditis was observed in all ages for both sexes but was substantially higher in those older than 40 years," the study's abstract states. "These findings have important implications for public health and vaccination policy."